Grape seed extract to improve liver function in patients with nonalcoholic fatty liver change

Saudi Journal of Gastroenterology

Volumn 16, Issue 3, 2010, Pages 194-197

  Khoshbaten, Manouchehr ^a   Aliasgarzadeh, Akbar ^a   Masnadi, Koorosh ^a   Farhang, Sara ^a   Tarzamani, Mohammad ^a   Babaei, Hosain ^a   Kiani, Javad ^a   Zaare, Maryam ^a   Najafipoor, Farzad ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Grape seed; liver function tests; liver hemodynamics; nonalcoholic fatty liver disease; treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ASCORBIC ACID; GRAPE SEED EXTRACT; ANTIOXIDANT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION; MALE; NONALCOHOLIC FATTY LIVER; RANDOMIZED CONTROLLED TRIAL; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG EFFECTS; ENZYMOLOGY; FATTY LIVER; LIVER FUNCTION TEST; METABOLISM; OXIDATIVE STRESS; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ANTIOXIDANTS; ASCORBIC ACID; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FATTY LIVER; FEMALE; GRAPE SEED EXTRACT; HUMANS; LIVER FUNCTION TESTS; MALE; OXIDATIVE STRESS; TREATMENT OUTCOME;

EID: 77954766363     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.65197     Document Type: Article

References (17)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231
2. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362
3. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:2485-2490
4. Patrick L. Nonalcohoic fatty liver disease: Relationship to insulin sensitivity and oxidative stress: Treatment approaches using vitamin E, magnesium and betaine. Altern Med Rev 2002;7:276-291
5. Sehirli O, Ozel Y, Dulundu E, Topaloglu U, Ercan F, Sener G. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother Res 2008;22:43-48
6. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997;95:179-189
7. Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 2008;269:243-261
8. Ray S, Bagchi D, Lim PM, Bagchi M, Gross SM, Kothari SC, et al. Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol 2001;109:165-197 (Pubitemid 33095142)
9. Chitturi S, Farrell GC. Etiopathogenesis of non-alcoholic steatohepatitis. Semin Liver Dis 2001;21:27-41.
10. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 2005;205:1-16.
11. Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev 2007;1:CD004996.
12. Morin B, Narbonne JF, Ribera D, Badouard C, Ravanat JL. Effect of dietary fat-soluble vitamins A and E and proanthocyanidin-rich extract from grape seeds on oxidative DNA damage in rats. Food Chem Toxicol 2008;46:787-796
13. El-Alfy AT, Ahmed AA, Fatani AJ. Protective effect of red grape seeds proanthocyanidins against induction of diabetes by alloxan in rats. Pharmacol Res 2005;52:264-270
14. Dulundu E, Ozel Y, Topaloglu U, Toklu H, Ercan F, Gedik N, et al. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction. J Gastroenterol Hepatol 2007;22:885-892 (Pubitemid 46911029)
15. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 2006;44:865-873
16. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006;22:437-443
17. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-107